• Bansal AK, Puri V, Chawla HPS and Kaul CL; Pharmaceutical composition of Ketorolac. App. No. 1032/DEL/2002, Patent No. 234519/2009

• Garg S, Vermani K, Arora P, Kohli G, Raghupathi K and Thambwekar K; A pharmaceutical composition of High Molecular Weight Polymeric Drugs. App. No. 735/DEL/2003, Patent No. 225919/2008.

• Jachak S, Ramchandran U, Mittal A, Ramarao P, Srinivasan K and Kaul CL; Naphthoquinones as antidiabetic agents.  App. No. 669/DEL/2004, Patent No. 218363/2008.

• Panchagnula R and Dhanikula A; A pharmaceutical composition for treating solid tumors and a method of preparing same thereof”, App. No. 777/DEL/2003, Patent No. 215478/2008.

• Ramachandran U, Takur A and Chawla HPS, Process for the preparation of 2-ethylhexyl 4-methoxycinnamate. App. No. 179/DEL/2004, Patent No. 217769/2008.

• Singh S and Kamala VRR; A process for preparing Casted Gelatin Containing Composition, App. No. 1111/DEL/2002, Patent No. 215811/2008.

• Banerjee A, Kaul P, Sharma R, Chawla HPS, Kaul CL and Banerjee UC; A process for preparing R-a-hydroxy arene acetic acid using a nitrilase from a bacterial source(Modified title in granted patent-" A process for hydrolyzing a racemic R Alpha-Hydroxy Arene acetonitrile into a R isomer of corresponding acid)”, App. No. 975/DEL/2003, Patent No. 197592/2007.

• Mittal S, Johar PS and Chawla HPS; Enzymatic process for the preparation of S-(+)-4(3-Thienyl) Phenyl-Alpha-Methylacetic Acid.  App. No. 875/DEL/2002, Patent No. 202332/2007.

• Chawla HPS, Johar PS, Mittal A, Meena RA and Negi VS; A process for the preparation of Methanone. (Ind)An improved one pot synthesis of [2,8-bis(trifluoromethyl)-4-quinolinyl-2-pyridinylmethanone, a mefloquine intermediate (US). App. No. 129/DEL/2001, Patent No.196969 (Ind.) 6500955 (US) CN1250540C(China)/2006.

• Garg S, Vermani K, Arora P, Kohli G, Raghupathi K and Thambwekar K; A process for preparation of Synergistic pharmaceutical composition”, App. No. 1033/DEL/2002, Patent No.196800/2006.

• Kumar N and Dey CS; Development of insulin non responsive skeletal muscle cell culture model to screen antidiabetic compounds against insulin resistance”, App. No. 09/984018(US), Patent No. 7052910 B2(US)/2006.

• Mittal S, Roy A and Chawla HPS; An improve process for the preparation of 4-(3-Thienyl) Phenyl-Alfa-Methylacetic Acid. App. No. 874/DEL/2002, Patent No.192069/2006.

• Ramachandran U, Chawla HPS, Kumar S and Wadhwa LK; A process for preparation of clopidogrel, App. No. 683/DEL/2002, Patent No. 193363/2006.

• Roy A, Kumar R, Chawla HPS and Banerjee UC; A novel microbial process for the preparation of S(-)-1-(1’-napthyl) ethanol from 1-acetonapthone”, App. No. 803/DEL/2002, Patent No. 199874 /2006.

• Vats P and Banerjee UC; A process for the production of extracellur phytase using a novel isolate of Aspergillus niger var teigham, App.No 0867/DEL/2003, Patent No. 197539 /2006.

• Roy A and Chawla HPS; An improved process for the preparation of isosorbide 2-acetate from isosorbide 2,5-diacetate.  App. No. 905/DEL/2001, Patent No. 193537/2004

• Zaneveld L, Anderson RA, Diao XH, Robert Y, Waller DP, Garg S and Chany CJ; Method for preventing sexually transmitted diseases. US Patent 6239182.

• Zaneveld L, Andersonc RA, Diao XH, Robert Y, Waller DP, Garg S and Chany CJ; Method for preventing sexually transmitted diseases.  US Patent 6028115.

• Zaneveld L, Anderson RA, Diao XH, Robert Y, Waller DP, Garg S and Chany CJ; Method for preventing sexually transmitted diseases. US Patent 5925621.

• Zaneveld L, Anderson RA, Diao XH, Robert Y, Waller DP, Garg S, Chany CJ; and Kim DS. Method for preventing sexually transmitted diseases. US Patent 5932619.

• Bansal AK, Munjal B and Patel S; Novel self-emulsifying curcumin compositions with enhanced bioavailability. App. No. PCT/IB/2009/005154, 2009.

• Bansal AK, Puri V, Kohli G and Ramarao P; Quick disintegrating taste masked composition. App. No. 2777/del/2008, 2009.

• Bhutani KK, Ahmed N, Brahmbhatt KG, Singh I and Mitra D and Sabde S; Novel anti-HIV compounds. App. No. 1556/DEL/2009.

• Bhutani KK, Ahmed N, Brahmbhatt KG, Singh I and Mitra D and Sabde S; Novel alkylated derivatives of quinoline 2,4-diol having anti-HIV activity.  App. No. 1557/DEL/2009.

• Chakraborti AK, Patel AR and Kumar D; An improved process for esterification using organic carbonates (Protic acid adsorbed on silica). App. No. 554/del/2009.

• Chakraborti AK, Patel AR, Kumar D and Bindal S; Novel catalytic system for esterification using organic carbonates. App. No. 1046/del/2009.

• Kumar N and Jain JP; Polymerosomes for controlled delivery of drugs. App. No.751/del/2009.

• Nair V and Roy N; Novel Androgen Receptor Modulators. App. No. 1178/del/2009.

• Singh IP, Bhutani KK, Mitra D, Chauthe SK, Bharate SB and Sabde S; Novel Dimeric phloroglucinol compounds as anti-HIV agents. App. No. 1055/DEL/2009.

• Bansal AK, Goyal MK, Roy I and Banerjee UC; A process for stabilization of lysozyme(A stabilized protein compositon). App. No. 1268/del/2008.

• Bansal AK, Munjal B and Patel SB; Novel, self nano emulsifying curcumin (curcuminoids) composition with enhanced bioavailability. App. No. 1776/del/2008.

• Chakraborti AK and  Chankeshwara SV; A novel dealkylation process. App. No. 1645/del/2008.

• Chakraborti AK and  Chankeshwara SV; A novel process for direct alkylation. App. No. 1107/del/2008.

• Chakraborti AK and  Chankeshwara SV; An improved organocatalytic process for esterification and amidation reaction. App. No. 1030/del/2008.

• Chakraborti AK, Banerjee UC, Kumar R, Garg SK and Meena VS; Novel Cyclooxygenase-2 inhibitors. App. No. 638/del/2008.

• Jain R and Sharma RK; A process for the synthesis of a-amino acid amides using unprotected a-amino acids under ambient reaction conditions and water as a solvent. App. No. 338/del/2008.

• Singh A, Basit A and Banerjee UC; An improved process for the enantioselective reduction of ezetimibe intermediate. App. No. 1909/del/2008.

• Vig A, Jain R, Sachdeva S and Hapargi G; An improved process for making intermediate for Pethidine Production. App. No. 1910/del/2008.

• Bansal AK and Puri V; Improved oral solid dosage form of celecoxib (Modified title- NOVEL FORMULATION OF CELECOXIB). App. No. 1300/del/2007.

• Bansal AK, Kumar L, Amin A, Jain R; Novel acid addition salts of enalapril. App. No. 1064/DEL/2007.

• Bansal AK, Kumar S, Chawla G; A process for producing spherical crystals of mebendazole. App.No. 951/DEL/2007.

• Bansal AK, Mohammad, GA and Puri V; An improved process for producing Stavudine polymorphic for. App. No.1256/del/2007.

• Bansal AK, Mohammad, GA and Puri V; Co-Processed APIs (Modified title- A pharmaceutical composition). App. No.1118/del/2007.

• Bansal AK, Puri V, Kohli G and Ramarao P; Quick disintegrating taste masked composition. App. No. 1488/del/2007.

• Chakraborti AK, Chankeshwara SV and Singh B; An improved solid support catalyst system for direct esterification reaction. App. No. 2764/DEL/2007.

• Kumar N and Jain JP; Injectable depot forming drug delivery system. App. No. 589/DEL/2007.

• Roy N and Agrawal V; Contaminating Insert Degradation by Prior-incubation (CIDP) Colony PCR: A novel unambiguous method for screening of recombinant clones.  Modified: CIDP: A method for screening recombinant clones. App. No. 1648/del/2007.

• Roy N and Pahwa S; Novel HIS4 gene from Geotrichum candidum. App. No: 1115/DEL/2007.

• Roy N, Pahwa S, Jain R, Monga V, Sharma RK and Rohilla RK; Ring modified Imidazoles as novel antifungal compounds targeted against fungal histidinol dehydrogenase. App.No. 1116/DEL/2007.

• Roy N, Pahwa S, Jain R, Monga V, Sharma RK, K RU and Chavan AG; A novel method for screening antifungal compounds targeted against fungal histidinol dehydrogenase. App.No: 1117/DEL/2007.

• Chitra G and Bhutani KK; Nutraceutical formulation; App. No. 505/DEL/2006.

• Jain R and Ahsan W; 4-Substituted-2,8-bis(trifluoromethyl) quinolines a new structural class of anti-tuberculosis agents. App. No. 1232/DEL/2006.

• Jain R and Ahsan W; A process for the synthesis of 4-substituted-2,8-bis(trifluoromethyl)quinolines a new structural class of anti-tuberculosis agents. App. No. 1233/DEL/2006.

• Jain R and Nayyar A; 4-(1-Admantyl)-2-substituted quinolines as new structural class of anti-tuberculosis agents. App. No. 1025/DEL/2006.

• Jain R and Nayyar A; A process for the synthesis of 4-(1-admantyl)-2-substituted quinolines as new structural class of anti-tuberculosis agents. App. No. 1024/DEL/2006.

• Jain R, Monga V and Kaur N; A process for the synthesis of CNS active thyrotropin-releasing hormone analogs. App. No. 2066/DEL/2006.

• Jain R, Monga V, Kaur N, Sharma SS, Kumar S, Roy N, Majumdar J, Agarwal S, Pawar C, Kadam RU and  Chavan A; CNS effective thyrotropin-releasing hormone analogs. Appl. No. 2065/DEL/2006.

• Jain R, Sharma RK and Sundriyal S; A process for the development of novel linear antimicrobial peptides (AMPs). App. No.1010/del/2006.

• Jain R, Sharma RK and Sundriyal S; Novel linear antimicrobial peptides (AMPs) effective against fungal and bacterial infections. App. No. 1011/DEL/2006.

• Ravi Kumar MNV, Bhardwaj V and Ankola DD; Polymeric nanoparticles of paclitaxel for treatment of cancers. App. No. 2636/DEL/2006.

• Ravi Kumar MNV, Italia JL, Bhatt D, Bhardwaj V and Tikoo KB; Nanoparticles containing cyclosporine. App. No. 1690/DEL/2006.

• Ravi Kumar MNV, Venkat Ratnam D, Sonaje K, Bhoomi V, Bhardwaj V and Ramarao P; Nano-co-encapsulated antioxidant particles (Nano CAPs). App. No. 1691/DEL/2006.

• RaviKumar MNV, Ankola DD, Bhoomi V, Bhardwaj Vivekanand and Ramarao P; Nanoparticulate formulation for oral delivery of Co-enzyme Q 10. App. No. 18/del/2006.

• RaviKumar MNV, Kashyap N, Bhoomi V, Bhardwaj V, Ramarao P and Kumar N; Design of Glucose Sensitive In-situ gelling system based on chitosan for pulsatile delivery of Insulin and use of thereof. App. No. 36/del/2006.

• Roy N and Pahwa S; A novel histidinol dehydrogenase from Geotrichum candidum. App. No. 348/del/2006.

• Roy N, Agrawal V and Banerjee UC; Recombinant AnigAP from Aspigillus niger van Teighem and use thereof.  App. No. 20/DEL/2006.

• Singh M, Khokale P, Rudrawar S, Banerjee UC and Chakraborti AK; A novel chemo-enzymatic process for synthesis of lubeluzole intermediate. App. No. 2570/DEL/2006.

• Banerjee A and Banerjee UC; A novel nitrilase gene from Pseudomonas putida. App. No. 2810/del/2005.

• Bansal AK and Kakumanu V; Method of improvement of bioavailability of prodrug, using self emulsifying drug delivery system. App. No. 3136/DEL/2005, 2005.

• Bansal AK and Kakumanu V; Method of improvement of bioavailability of prodrug using solid lipid nanoparticles. App. No. 3139/DEL/2005, 2005.

• Bansal AK, Arora S, Kaushal AM; Improved sustained release ropinirole. App. No. 2755/DEL/2005.

• Bansal AK, Banga S and Chawla G; A process for producing improved celecoxib crystals. App. No. 2709/DEL/2005.

• Bansal AK, Kakumanu V and Arora VK; Gastroretentive dosage form of cephalosporin, and process of preparation thereof. App. No. 3137/DEL/2005, 2005.

• Bansal AK, Kakumanu V and Arora VK; Pharmaceutical composition of cefpodoxime proxetil and cyclodextrin; and process of preparation thereof. App. No. 3140/DEL/2005, 2005.

• Chitra G, Bhutani KK, Kartha KPR and Singh IP; Novel polysaccharides with cytotoxic activity. App. No. 667/DEL/2005.

• Chitra G, Bhutani KK, Kartha KPR and Singh IP; Novel polysaccharides with antioxidant activity. App. No. 668/DEL/2005.

• Jain R, Jain M, Singh PP, Singh S, Sachdeva S, Misra V, Ramarao P, Kaul CL and Tikoo K; A process for preparation of ring-substituted 8-aminoquinoline analogues as antimalarial agents. PCT App. No. PCT/IB03/06362, 2005.Ramachandran U, Mittal A and Kumar R; An improved process for the preparation of S-citalopram. App. No. 2524/del/2005.

• Banerjee A, Kaul P, Sharma R, Singh HPS, Kaul CL and Banerjee UC; A process for hydrolyzing a racemic R-a-hydroxy arene acetonitrile into (R) isomer of corresponding acid. App. No. 2128/DEL/2004.

• Bansal AK, Trasi N, Kaushal AN, Banerjee UC and Roy N; A stable phytase preparation. App. No. 2557/del/2004.

• Chawla HPS, Mittal S, Johar PS, Ramarao P and Shivarudraiah AKH; New Nitric Oxide releasing derivatives of S-4-(3-thienyl)phenyl--methyl-acetic acid, App. No. IPO 1495-RH/SGM, 2004.

• Chelliah S, Jachak SM, Thilagavathi R and Chakraborti AK; Novel anti-inflammatory and antioxidant compounds. App. No. 1704/Del/2004.

• Jain R, Jain M, Singh PP, Singh S, Sachdeva S, Misra V, Ramarao P, Kaul CL and Tikoo K; A process for preparation of ring-substituted 8-aminoquinoline analogues as antimalarial agents. US Patent App. No. 10/737589, 2004.

• Kumar S and Ramachandran U; A process for preparation of  levobupivacaine. App. No. 1667/Del/2004.

• Soni P and Banerjee UC; A novel microbial biocatalyst for oxido reduction reactions. App. No. 440/DEL/2004.

• Soni P, Kaul CL and Banerjee UC; A novel process for the synthesis of a duloxetine intermediate, (S)-N,N,dimethyl-3-hydroxy-3-(2-thienyl)-1-propanamine. App. No. 1573/DEL/2004.

• Bansal AK and Nachaegari SK; A pharmaceutical excipient having improved compressibility for application in direct compression tableting. App.No. 807/DEL/2003.

• Chakraborti AK and Gulhane R; A process for the acylation of various substrates using a solid support catalyst. App. No 266/DEL/2003.

• Chakraborti AK and Gulhane R; Method for acylation using Zirconium (IV) compound as catalysts. App. No 336/DEL/2003.

• Chakraborti AK and Kondaskar A; An improved process for the preparation of aminoalcohols. App. No 337/DEL/2003.

• Garg S Tambwekar KR, Jhamb SS, Raghupathi K, Vermani K, Kaul CL, Chany C, Anderson RA Jr., Weller DP and Zaneveld L; A pharmaceutical formulation having antiviral and contraceptive property. App. No 2/DEL/2003.

• Garg S, Jambu L, Vermani K, Kohli G, Raghupathi K, Tambwekar KR and Kaul CL. A sustained release bioadhesive formulation of an iodophore. App. No 105/DEL/2003.

• Garg S, Vermani K, Kohli G, Raghupathi K, Tambwekar  KR and Kaul CL; A process for the preparation of rapidly disintegrating and bioadhesive formulation App. No 267/DEL/2003.

• Jain R, Jain M, Singh PP, Singh S, Sachdeva S, Misra V, Ramarao P and Kaul CL; A process for preparation of ring-substituted 8-aminoquinoline analogues as antimalarial agents App.No 473/DEL/2003.

• Jain R, Jain M, Singh PP, Singh S, Sachdeva S, Misra V, Ramarao P and Kaul CL; Ring-substituted 8-aminoquinoline analogues as antimalarial agents. App.No 459/DEL/2003.

• Panchagnula R and Dhanikula A; Process for preparing a thermoreversible liposomal gel for cancer therapy. App. No 795/DEL/2003.

• Panchagnula R and Dhanikula A; Thermoreversible liposomal gel for cancer therapy. App. No. 796/DEL/2003.

• Panchagnula R, Gandhi R and Kaul CL; A Novel Controlled release formulation of Azithromycin. App. No 1025/DEL/2003.

• Ramachandran U, Kumar R, Mittal A, Ramaao P, Srinivasan K, Dey CS, Ishrath A, Chawla HPS and Kaul CL; Tricyclic compounds having antioxidant properties. App. No 1268/DEL/2003.

• Selvam C, Jachak SM, Gnana Oli R and Bhutani KK; New anti-inflammatory compounds from Indigofera aspalathoides. App. No 1489/DEL/2003.

• Sharma R, Singh S, Roy A, Chawla HPS, Kaul CL and Banerjee UC; An improved process for enantioselective hydrolysis of trans-MPGM. App. No. 1358/DEL/2003.

• Bansal AK and Verma S; A process for coating highly water-soluble drugs. App. No. 1210/DEL/2002.

• Bansal AK and Verma S; A taste masking pharmaceutical composition. App.No 1164/DEL/2002.

• Bansal AK, Gupta P and Kakumanu VK; A process for the preparation of celecoxib composition with improved aqueous solubility. App.No 1165/DEL/2002.

• Bansal AK, Gupta P and Kakumanu VK; A synergistic pharmaceutical composition of celecoxib with improved aqueous solubility. App.No 685/DEL/2002.

• Bansal AK, Gupta P and Kakumanu VK; Ternary amorphous systems for improving aqueous solubility of poorly water soluble drugs. App.No 682/DEL/2002

• Chakraborti K and Kondaskar A; An improved process for preparation of hydroxyalkyl and hydroxyaryl sulfides. App.No 1209/DEL/2002.

• Jain R, Vaitilingam B, Nayyar AR, Bhaskar PP, Singh PP, Jain M, Sachdeva S, Misra V, Kaur Sukhraj and Kaul C; Ring-substituted quinoline analogues as anti-tuberculosis agents. App. No.628/DEL/2002.

• Jain R, Vengapandu S, Singh PP, Kinhikar AG, Singh S, Jain M, Sachdeva S, Misra V, Ramarao P and Kaul CL; Quinoline analogues with broad-spectrum antimalarial activities, App. No. 1112/DEL/2002.

• Garg S, Verma RK and Kaul CL; A Pharmaceutical composition for extended release of a Therapeutically Active Ingredient. App. No 96/DEL/2001.

• Garg S, Verma RK and Kaul CL; A tablet composition useful for extended release of isosorbide mononitrate. App.No 698/DEL/2001.

• Gogia A, Bansal AK and Arora VK; Process for the preparation of aqueous pharmaceutical compositions of fluoroquinolones. App. No. 197/DEL/2000, 2000.

TOP

National Institute of Pharmaceutical Education and Research (NIPER)
Sector 67, Phase X, S.A.S. Nagar, (Punjab) INDIA-160062
Phone - +91-172-2214682-87, Fax-+91-172-2214692